EUVIMEDEUVIMED entdecken
Crossref

Analysing compliance with calcium and vitamin D supplementations in cancer patients receiving bone resorptive agents

Jermaine Coward iD, Ashleigh Kate Smith iD

Journal of Oncology Pharmacy Practice · 25.05.2026

DOI: 10.1177/10781552261448813 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Oncology Pharmacy Practice, online erschienen am 25.05.2026. Verfasst von Jermaine Coward und 1 weiteren Autor:innen. Beteiligte Einrichtung: Icon Cancer Centre South Brisbane, Icon Cancer Centres, Australia. Die Arbeit nennt 6 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To assess patient-reported compliance with calcium and vitamin D supplementation and identify barriers in oncology patients prescribed bone resorptive therapy.

Methods

A multicentre observational study was conducted across several private day oncology infusion units within Australia. Adult cancer patients receiving denosumab, pamidronate, or zoledronic acid were identified. Eligible patients (excluding those with pre-existing osteoporosis or hypercalcaemia of malignancy) completed a 13-item survey including the MMAS-8 adherence scale. Clinical data were extracted from the CHARM prescribing system. Descriptive and comparative analyses were performed.

Results

80 people participated. 45% were reported being prescribed calcium and vitamin D supplements; 46.25% denied supplementation and 9% were unsure. Among prescribed patients, the mean MMAS-8 score was 6.86, indicating medium adherence. Hypocalcaemia occurred in 27.5% of patients, 60% of whom reported no supplementation. Vitamin D levels were unavailable in 55% of cases.

Conclusion

Under-prescribing and poor monitoring of calcium and vitamin D supplements are prevalent. Systematic supplementation protocols and pharmacist-led education could improve adherence and reduce skeletal-related complications.

Schlagwörter

Stichwörter der Autor:innen

Calcium supplementationadherencebone resorptive agentsoncology pharmacyvitamin D

Autor:innen und Institutionen

  • Icon Cancer Centre South Brisbane, Icon Cancer Centres, Australia.
  • Pharmacy - Icon Cancer Centre South Brisbane, Icon Cancer Centres, Australia.

ORCID-Profile: Jermaine Coward, Ashleigh Kate Smith

Zitieren

APA

Coward, J., & Smith, A. K. (2026). Analysing compliance with calcium and vitamin D supplementations in cancer patients receiving bone resorptive agents. Journal of Oncology Pharmacy Practice. https://doi.org/10.1177/10781552261448813

Vancouver

Coward J, Smith AK. Analysing compliance with calcium and vitamin D supplementations in cancer patients receiving bone resorptive agents. Journal of Oncology Pharmacy Practice. 2026. doi:10.1177/10781552261448813

BibTeX
@article{Coward2026,
  author = {Coward, Jermaine and Smith, Ashleigh Kate},
  title = {Analysing compliance with calcium and vitamin D supplementations in cancer patients receiving bone resorptive agents},
  journal = {Journal of Oncology Pharmacy Practice},
  year = {2026},
  doi = {10.1177/10781552261448813}
}
Kostenlos starten →